Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21370276 | 0.97 | ATM (0.39) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21370359 | 0.97 | ATM (0.39) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21369843 | 0.97 | KDM4E (0.39) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL21369790 | 0.97 | ATM (0.39) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21369658 | 0.96 | L3MBTL1 (0.43) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21370287 | 0.95 | L3MBTL1 (0.44) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL21370156 | 0.95 | ATM (0.41) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21369842 | 0.95 | ATM (0.41) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL22386999 | 0.95 | KDM4E (0.41) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL22387034 | 0.95 | KDM4E (0.41) | KDM4EATML3MBTL1RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190288215-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SOULBRAIN CO., LTD. (KR) | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190288215-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, CYP1B1 | KDM4E 2473/4885ATM 3568/4885L3MBTL1 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.